FDA Approval of Venetoclax in Combination with Rituximab (V+R) for Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Patients Who Have Received One Prior Therapy
September is Blood Cancer Awareness Month around the globe.
September 15th is World Lymphoma Awareness Day.
Our fellow blood cancer charities are all working hard to raise awareness.
The CLL Society is proud to be a member of the Lymphoma Coalition that is using the hash tags: #WLAD and #Everythingchanges to focus on how small changes can make a world of difference.
Here is the link to the resources from The Leukemia & Lymphoma Society (LLS) for this special month.
LRF or the Lymphoma Research Foundation has planned among other things its powerful annual Light it Red for Lymphoma where famous landmarks around the world are flooded in bright red lights.
The United Kingdom’s Leukaemia Care has its spotty campaign #spotleukaemia urging us to spot the early signs of our cancer.
Other charities around the world are addressing the particular issues in their countries.
We at the not-for-profit CLL Society are doing our best to raise awareness with several campaigns and efforts this month focused specifically on CLL.
Our motto for Blood Cancer Awareness Month is “The More Aware, the Better the Care”.
The issues are somewhat different for CLL patients as I explain in this short video. Read the transcript here.
What isn’t different is the need to be aware and smart about our disease. Please help us to help others become more educated and aware though our “adopt a CLL patient” program with a donation to the CLL Society in Blood Cancer Awareness Month.
Stay strong.
We are all in this together
Brian Koffman, MD 9-5-17
Related posts